Cabazitaxel

Author:Prof. Dr. med. Peter Altmeyer

Last updated on: 23.02.2021

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

Go toThis section has been translated automatically.

Cytostatic drug belonging to the taxanes, derivative of docetaxel used in second-line therapy of hormone-refractory metastatic prostate carcinoma.

Authors

Last updated on: 23.02.2021

Author: Prof. Dr. med. Peter Altmeyer